Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery [Phase 4]
Phase 4 trial update on continuous popliteal block for microvascular free flap reconstruction in head and neck surgery; study completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Mirthful Laughter and Muscle Soreness / Pain [NA]
A completed clinical trial investigating pain with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Effects of Intramuscular Oxytocin on Sensory Function in Healthy Volunteers With Ultraviolet Burn Injury to the Skin [Phase 4]
Phase 4 trial evaluating intramuscular oxytocin for effects on sensory function in healthy volunteers with UV-induced skin burn; results pos…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Effects of Lavender Oil on Postoperative Pain, Sleep Quality and Mood [Phase 3]
Phase 3 clinical trial investigating the effects of lavender oil on postoperative pain, sleep quality, and mood has completed with results p…
-
CLINICAL_TRIALS research · 2021-03-24Clinical Trial Update: Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar [Phase 4]
Phase 4 trial evaluating tramadol hydrochloride with dexketoprofen trometamol for moderate to severe acute pain after removal of impacted lo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: The Maternal and Perinatal Outcomes Associated With the Use of Non-pharmacological in Labor [NA]
Clinical trial update on maternal and perinatal outcomes associated with non-pharmacological labor methods; results posted after completion.
-
CLINICAL_TRIALS research · 2021-03-17Clinical Trial Update: Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury [NA]
A completed clinical trial evaluating the effects of transcranial direct current stimulation (tDCS) on neuropathic symptoms after burn injur…
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Optimal Stimulation Programming for Spinal Peripheral Neuromodulation [NA]
A completed clinical trial evaluating optimal stimulation programming for spinal peripheral neuromodulation in chronic pain.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating gonyautoxin 2/3 for acute back pain has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department [Phase 4]
Phase 4 trial assessing low-dose ketamine as an adjunct to opiates for acute pain in emergency department; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Ethyl Chloride for NPWT [Phase 4]
Phase 4 clinical trial update on the use of Ethyl Chloride for negative-pressure wound therapy (NPWT) in acute pain conditions; study comple…
-
FDA approval · 2021-03-05FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for butorphanol tartrate from Apotex Corp., updating the product labeling.
-
FDA approval · 2021-03-04FDA Approved: HYDROMORPHONE HYDROCHLORIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for Hydromorphone Hydrochloride from Padagis US LLC. The supplemental approval pertains to a generic…
-
FDA approval · 2021-03-04FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application to market a hydrocodone bitartrate and acetaminophen combination product from Amneal Pharmaceuti…
-
FDA approval · 2021-03-04FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen from Amneal Pharmaceuticals LLC under the ANDA process.
-
FDA approval · 2021-03-04FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Acetaminophen and Codeine Phosphate from Strides Pharma Science Limited under the approved ANDA.…
-
FDA approval · 2021-03-04FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for MS CONTIN (morphine sulfate) by Rhodes Pharmaceuticals L.P.
-
FDA approval · 2021-03-04FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)
FDA approved SpecGx LLC's supplemental application for a generic oxycodone hydrochloride and acetaminophen product (Oxycodone and acetaminop…
-
FDA approval · 2021-03-04FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (FH2 Pharma LLC)
FDA approved FH2 Pharma LLC's supplemental application for OXYCODONE AND ACETAMINOPHEN tablets, enabling its marketing as a generic product …
-
FDA approval · 2021-03-04FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for tapentadol hydrochloride (brand Tapentadol) submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2021-03-04FDA Approved: ROXICODONE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Roxicodone (oxycodone hydrochloride) submitted by SpecGx LLC.
-
FDA approval · 2021-03-04FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for HYDROCODONE BITARTRATE AND ACETAMINOPHEN from Hikma Pharmaceuticals USA Inc., indicating an appr…
-
FDA approval · 2021-03-04FDA Approved: TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Trigen Laboratories, LLC)
The FDA approved a supplemental NDA for tramadol hydrochloride extended-release submitted by Trigen Laboratories, LLC, resulting in approval…
-
FDA approval · 2021-03-04FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved Epic Pharma's supplemental application for oxymorphone hydrochloride, authorizing the generic product as an analgesic for pain …
-
FDA approval · 2021-03-04FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
FDA approved a supplemental application for buprenorphine hydrochloride filed by Advagen Pharma Ltd under the ANDA, authorizing changes to t…